Current trends in theranostics for rheumatoid arthritis

被引:36
作者
Madav, Yamini [1 ]
Barve, Kalyani [1 ]
Prabhakar, Bala [1 ]
机构
[1] SVKMs NMIMS, Shobhaben Pratapbhai Patel Sch Pharm & Technol Ma, VL Mehta Rd, Mumbai 400056, Maharashtra, India
关键词
Nanotechnology; Photodynamic therapy; Imaging; Diagnosis; CITRULLINATED PEPTIDE ANTIBODY; PHOTODYNAMIC THERAPY; GOLD NANOPARTICLES; DISEASE-ACTIVITY; MORTALITY; PHOTOSENSITIZERS; NANOMEDICINE; METHOTREXATE; MANAGEMENT; SCORE;
D O I
10.1016/j.ejps.2020.105240
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The very complexity of Rheumatoid Arthritis (RA) makes its prognosis and management challenging. The manifestations pertaining to RA emerge in the late stage of the disease when the damage to bone and cartilage has already occurred. Therefore early diagnosis of RA becomes critical in order to avoid further complications and disabilities. In such a scenario, theranostics can be an ideal solution to tackle the barriers to disease management in RA patients. Nanotechnology has paved the way for emerging theranostics to achieve better targetability and high performance. The shortcomings of current diagnostic techniques and pharmacological treatment are addressed in this review. The article also summarizes the laboratory studies that have reported promising theranostic entities for RA diagnosis, treatment and discusses the outcomes of each. Novel platforms combined with newer techniques have found application in the theranostics of RA. These platforms include gold nanorods, nanoshells, nanowhiskers, magnetic nanoparticles, solid and mesoporous silica nanoparticles, etc. Photodynamic, chemo-photo responsive, magnetic field based imaging and simultaneous stimulation have been reported for the release of therapeutic moieties from these nanoplatform. Theranostics can also assist clinicians in determining the respondents and non-respondents to biological response modifiers and other treatments available for RA. This not only plays an important role in selecting the suitable therapy for every patient but also in monitoring the progress of treatment in the patient. The advantages of theranostics over current diagnosis and treatment for RA are tremendous. Hence it holds great opportunities for progress and enhancement of RA disease management.
引用
收藏
页数:9
相关论文
共 79 条
[21]   EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis [J].
Colebatch, Alexandra N. ;
Edwards, Christopher John ;
Ostergaard, Mikkel ;
van der Heijde, Desiree ;
Balint, Peter V. ;
D'Agostino, Maria-Antonietta ;
Forslind, Kristina ;
Grassi, Walter ;
Haavardsholm, Espen A. ;
Haugeberg, Glenn ;
Jurik, Anne-Grethe ;
Landewe, Robert B. M. ;
Naredo, Esperanza ;
O'Connor, Philip J. ;
Ostendorf, Ben ;
Potocki, Kristina ;
Schmidt, Wolfgang A. ;
Smolen, Josef S. ;
Sokolovic, Sekib ;
Watt, Iain ;
Conaghan, Philip G. .
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (06) :804-814
[22]   Temperature-responsive polymeric nanospheres containing methotrexate and gold nanoparticles: A multi-drug system for theranostic in rheumatoid arthritis [J].
Costa Lima, Sofia A. ;
Reis, Salette .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2015, 133 :378-387
[23]   Non-pharmacological interventions for fatigue in rheumatoid arthritis [J].
Cramp, Fiona ;
Hewlett, Sarah ;
Almeida, Celia ;
Kirwan, John R. ;
Choy, Ernest H. S. ;
Chalder, Trudie ;
Pollock, Jon ;
Christensen, Robin .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (08)
[24]   Nonpharmacological Treatment of Pain in Rheumatic Diseases and Other Musculoskeletal Pain Conditions [J].
Cunningham, Natoshia Raishevich ;
Kashikar-Zuck, Susmita .
CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (02)
[25]   Mortality in rheumatoid arthritis over the last fifty years: Systematic review and meta-analysis [J].
Dadoun, Sabrina ;
Zeboulon-Ktorza, Nadine ;
Combescure, Christophe ;
Elhai, Muriel ;
Rozenberg, Sylvie ;
Gossec, Laure ;
Fautrel, Bruno .
JOINT BONE SPINE, 2013, 80 (01) :29-33
[26]   RABIOPRED, AN INNOVATIVE THERANOSTIC TOOL TO ASSIST CLINICIANS SELECT AN OPTIMAL ANTI-TNF ALPHA BIOLOGICAL THERAPY FOR RHEUMATOID ARTHRITIS PATIENTS [J].
Danilin, S. ;
Schordan, E. ;
Coq, M. ;
Abbinazi, S. Ait ;
Mehdi, M. ;
Firat, H. ;
Arber, N. ;
Breuil, V. ;
Demoux, A. -L. ;
Gul, A. ;
Gottenberg, J. -E. ;
Hatemi, G. ;
Huizinga, T. ;
Inanc, N. ;
Vencovsky, J. ;
Jorgensen, C. .
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 :857-857
[27]   TARGETING ACTIVATED SYNOVIAL FIBROBLASTS USING PHOTODYNAMIC THERAPY IN RHEUMATOID ARTHRITIS [J].
Dorst, D. N. ;
Rijpkema, M. ;
Buitinga, M. ;
Brom, M. ;
Bos, D. L. ;
Freimoser, A. ;
Klein, C. ;
Walgreen, B. ;
van der Kraan, P. ;
Gotthardt, M. ;
Koenders, M. I. .
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 :894-895
[28]  
Efthimiou Petros, 2010, HSS J, V6, P108, DOI 10.1007/s11420-009-9133-8
[29]  
Gavrila B I, 2016, J Med Life, V9, P144
[30]   The Employee Absenteeism Costs of Rheumatoid Arthritis Evidence From US National Survey Data [J].
Gunnarsson, Candace ;
Chen, Jie ;
Rizzo, John A. ;
Ladapo, Joseph A. ;
Naim, Ahmad ;
Lofland, Jennifer H. .
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2015, 57 (06) :635-642